Title |
Cost-effectiveness of family history-based colorectal cancer screening in Australia
|
---|---|
Published in |
BMC Cancer, April 2014
|
DOI | 10.1186/1471-2407-14-261 |
Pubmed ID | |
Authors |
Driss A Ouakrim, Alex Boussioutas, Trevor Lockett, John L Hopper, Mark A Jenkins |
Abstract |
With 14.234 diagnoses and over 4047 deaths reported in 2007, colorectal cancer (CRC) is the second most common cancer and second most common cause of cancer-related mortality in Australia. The direct treatment cost has recently been estimated to be around AU$1.2 billion for the year 2011, which corresponds to a four-fold increase, compared the cost reported in 2001. Excluding CRCs due to known rare genetic disorders, 20% to 25% of all CRCs occur in a familial aggregation setting due to genetic variants or shared environmental risk factors that are yet to be characterised. A targeted screening strategy addressed to this segment of the population is a potentially valuable tool for reducing the overall burden of CRC. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Saudi Arabia | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Unknown | 65 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 18% |
Student > Master | 10 | 15% |
Student > Ph. D. Student | 8 | 12% |
Student > Doctoral Student | 4 | 6% |
Student > Bachelor | 4 | 6% |
Other | 16 | 24% |
Unknown | 12 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 42% |
Social Sciences | 4 | 6% |
Business, Management and Accounting | 3 | 5% |
Nursing and Health Professions | 3 | 5% |
Economics, Econometrics and Finance | 3 | 5% |
Other | 9 | 14% |
Unknown | 16 | 24% |